Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations

OBJECTIVE: To investigate whether SARS-CoV-2 omicron breakthrough infection in individuals after three doses of wildtype-based BNT162b2 increases antibody levels measured by a commercially available wildtype-based immunoassay. METHODS: 16 of 21 individuals in a BNT162b2 vaccination cohort (recruited...

Descripción completa

Detalles Bibliográficos
Autores principales: Perkmann, Thomas, Springer, David N., Mucher, Patrick, Wolzt, Michael, Weseslindtner, Lukas, Haslacher, Helmuth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299948/
https://www.ncbi.nlm.nih.gov/pubmed/37398629
http://dx.doi.org/10.1016/j.jcvp.2023.100157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299948/
https://www.ncbi.nlm.nih.gov/pubmed/37398629
http://dx.doi.org/10.1016/j.jcvp.2023.100157

Ejemplares similares